The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.
Open accessAbstract
We previously reported that high density lipoprotein (HDL) protects against the oxidative modification of low density lipoprotein (LDL) induced by artery wall cells causing these cells to produce pro-inflammatory molecules. We also reported that enzyme systems associated with HDL were responsible for this anti-inflammatory property of HDL. We now report studies comparing HDL before and during an acute phase response (APR) in both humans and a croton oil rabbit model. In rabbits, from the onset of APR the protective effect of HDL progressively decreased and was completely lost by day three. As serum amyloid A (SAA) levels in acute phase HDL (AP-HDL) increased, apo A-I levels decreased 73%. Concomitantly, paraoxonase (PON) and platelet activating factor acetylhydrolase (PAF-AH) levels in HDL declined 71 and 90%, respectively, from days one to three. After day three, there was some recovery of the protective effect of HDL. AP-HDL from human patients and rabbits but not normal or control HDL (C-HDL) exhibited increases in ceruloplasmin (CP). This increase in CP was not seen in acute phase VLDL or LDL. C-HDL incubated with purified CP and re-isolated (CP-HDL), lost its ability to inhibit LDL oxidation. Northern blot analyses demonstrated enhanced expression of MCP-1 in coculture cells treated with AP-HDL and CP-HDL compared to C-HDL. Enrichment of human AP-HDL with purified PON or PAF-AH rendered AP-HDL protective against LDL modification. We conclude that under basal conditions HDL serves an anti-inflammatory role but during APR displacement and/or exchange of proteins associated with HDL results in a pro-inflammatory molecule.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
Havel, R. J., Eder, H. A., & Bragdon, J. H. (1955) · Journal of Clinical Investigation · doi:10.1172/jci103182 · Cited by 8,760
Role of oxidized low density lipoprotein in atherogenesis.
Witztum, J. L., & Steinberg, D. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115499 · Cited by 2,675
The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,357
Pepys, M. B., & Baltz, M. L. (1983) · Advances in Immunology · doi:10.1016/s0065-2776(08)60379-x · Cited by 1,272
Cushing, S. D., Berliner, J. A., Valente, A. J., Territo, M. C., Navab, M., Parhami, F., Gerrity, R., Schwartz, C. J., & Fogelman, A. M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5134 · Cited by 1,146
Self-citationParaoxonase prevents accumulation of lipoperoxides in low‐density lipoprotein
Mackness, M. I., Arrol, S., & Durrington, P. N. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80962-3 · Cited by 977
High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein
Parthasarathy, S., Barnett, J., & Fong, L. G. (1990) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(90)90314-n · Cited by 827
NHLBI funding policies. Enhancing stability, predictability, and cost control.
Lenfant, C. (1994) · Circulation · doi:10.1161/01.cir.90.1.1 · Cited by 762
Navab, M., Imes, S. S., Hama, S. Y., Hough, G. P., Ross, L. A., Bork, R. W., Valente, A. J., Berliner, J. A., Drinkwater, D. C., & Laks, H. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115532 · Cited by 737
Self-citationGan, K. N., Smolen, A., Eckerson, H. W., & La Du, B. N. (1991) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07065-5 · Cited by 596
Self-citationEstablishment of a human cell line (mono mac 6) with characteristics of mature monocytes
Ziegler‐Heitbroc, H. W. L., Thiel, E., Futterer, A., Herzog, V., Wirtz, A., & Riethmüller, G. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410324 · Cited by 553
Hessler, J. R., Robertson, A. L., & Chisolm, G. M. (1979) · Atherosclerosis · doi:10.1016/0021-9150(79)90166-7 · Cited by 505
Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus
Mackness, M. I., Harty, D., Bhatnagar, D., Winocour, P. H., Arrol, S., Ishola, M., & Durrington, P. N. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90215-o · Cited by 492
The Metabolic Role of Lecithin: Cholesterol Acyltransferase: Perspectives from Pathology
GLOMSET, J. A., & NORUM, K. R. (1973) · Advances in Lipid Research · doi:10.1016/b978-0-12-024911-4.50008-8 · Cited by 473
Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.
Gerrity, R. G., Naito, H. K., Richardson, M., & Schwartz, C. J. (1979) · PubMed · Cited by 466
Watson, A. D., Navab, M., Hama, S. Y., Sevanian, A., Prescott, S. M., Stafforini, D. M., McIntyre, T. M., Du, B. N., Fogelman, A. M., & Berliner, J. A. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117726 · Cited by 403
Self-citationCeruloplasmin. A scavenger of superoxide anion radicals.
Goldstein, I. M., Kaplan, H. B., Edelson, H. S., & Weissmann, G. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50692-x · Cited by 365
BLATTER, M., JAMES, R. W., MESSMER, S., BARJA, F., & POMETTA, D. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17620.x · Cited by 347
Cabana, V. G., Siegel, J. N., & Sabesin, S. M. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38390-5 · Cited by 300
A Fluorescence-Based Protein Assay for Use with a Microplate Reader
Lorenzen, A., & Kennedy, S. W. (1993) · Analytical Biochemistry · doi:10.1006/abio.1993.1504 · Cited by 292
Role of oxidized low density lipoprotein in atherogenesis
Parthasarathy, S., & Rankin, S. M. (1992) · Progress in Lipid Research · doi:10.1016/0163-7827(92)90006-5 · Cited by 290
Intact human ceruloplasmin oxidatively modifies low density lipoprotein.
Ehrenwald, E., Chisolm, G. M., & Fox, P. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117127 · Cited by 261
Redox cycling of iron and lipid peroxidation
Minotti, G., & Aust, S. D. (1992) · Lipids · doi:10.1007/bf02536182 · Cited by 249
Caeruloplasmin: Physiological and Pathological Perspectives
Gutteridge, J. M. C., & Stocks, J. (1981) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368109105866 · Cited by 217
Steinbrecher, U. P., & Pritchard, P. H. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38359-0 · Cited by 215
Influence of mouse apolipoprotein A-II on plasma lipoproteins in transgenic mice.
Hedrick, C. C., Castellani, L. W., Warden, C. H., Puppione, D. L., & Lusis, A. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80777-7 · Cited by 175
Cheung, M. C., Wolf, A. C., Lum, K. D., Tollefson, J. H., & Albers, J. J. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38747-2 · Cited by 172
Inhibition of superoxide and ferritin-dependent lipid peroxidation by ceruloplasmin
Samokyszyn, V. M., Miller, D. M., Reif, D. W., & Aust, S. D. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31218-8 · Cited by 166
Role of endothelial cells and their products in the modification of low-density lipoproteins
van Hinsbergh, V. W. M., Scheffer, M., Havekes, L., & Kempen, H. J. M. (1986) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(86)90343-7 · Cited by 159
Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein.
Benditt, E. P., Eriksen, N., & Hanson, R. H. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.8.4092 · Cited by 151
The inhibition of lipid autoxidation by human caeruloplasmin
Al-Timimi, D. J., & Dormandy, T. L. (1977) · Biochemical Journal · doi:10.1042/bj1680283 · Cited by 141
Ohta, T., Takata, K., Horiuchi, S., Morino, Y., & Matsuda, I. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81590-x · Cited by 126
Navab, M., Hough, G. P., Stevenson, L. W., Drinkwater, D. C., Laks, H., & Fogelman, A. M. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113802 · Cited by 123
Self-citationLenten, B. J. V., & Fogelman, A. M. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.1.112 · Cited by 116
Self-citationAntioxidants and atherosclerosis: A current assessment
Chisolm, G. M. (1991) · Clinical Cardiology · doi:10.1002/clc.4960141304 · Cited by 99
Acidic pH enables caeruloplasmin to catalyse the modification of low‐density lipoprotein
Lamb, D. J., & Leake, D. S. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80348-x · Cited by 95
Stafforini, D. M., Zimmerman, G. A., McIntyre, T. M., & Prescott, S. M. (1992) · PubMed · Cited by 90
Self-citation[39] Platelet-activating factor acetylhydrolase from human plasma
Stafforini, D. M., McIntyre, T. M., & Prescott, S. M. (1990) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(90)87041-z · Cited by 85
Self-citationLow density lipoprotein oxidation by stimulated neutrophils and ferritin
Abdalla, D. S. P., Čampa, A., & Monteiro, H. P. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90128-4 · Cited by 76
Is paraoxonase related to atherosclerosis
Mackness, M., Arrol, S., Abbott, C. A., & Durrington, P. N. (1993) · Chemico-Biological Interactions · doi:10.1016/0009-2797(93)90038-z · Cited by 65
Molecular and cellular biology of serum amyloid A.
Rienhoff, H. Y., Huang, J. H., Li, X. X., et al. (1990) · PubMed · Cited by 39
Zahedi, K. A., Gonnerman, W. A., deBeer, F. C., DeBeer, M. C., Steel, D. M., Sipe, J. D., & Whitehead, A. S. (1991) · Inflammation · doi:10.1007/bf00917905 · Cited by 24
Self-citation
Cited by
Advances in metal-induced oxidative stress and human disease
Jomova, K., & Valko, M. (2011) · Toxicology · doi:10.1016/j.tox.2011.03.001 · Cited by 3,207
Khovidhunkit, W., Kim, M.-S., Memon, R. A., Shigenaga, J. K., Moser, A. H., Feingold, K. R., & Grunfeld, C. (2004) · Journal of Lipid Research · doi:10.1194/jlr.r300019-jlr200 · Cited by 1,481
Cholesterol, inflammation and innate immunity.
Tall, A. R., & Yvan-Charvet, L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3793 · Cited by 1,479
Antiinflammatory Properties of HDL
Barter, P. J., Nicholls, S., Rye, K.-A., Anantharamaiah, G. M., Navab, M., & Fogelman, A. M. (2004) · Circulation Research · doi:10.1161/01.res.0000146094.59640.13 · Cited by 1,394
Self-citationThe Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
Metadata
- Authors
- Van Lenten, B. J., Hama, S. Y., de Beer, F. C., Stafforini, D. M., McIntyre, T. M., Prescott, S. M., La Du, B. N., Fogelman, A. M., & Navab, M.
- Venue
- Journal of Clinical Investigation
- Published
- 1995-12-01
- Volume
- 96
- Issue
- 6
- Pages
- 2758-2767
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2031805664
- Cited by
- 840
- References
- 46
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.